136 related articles for article (PubMed ID: 20509125)
1. [Erythropoiesis stimulating proteins for the treatment of anemia in cancer patients].
Burger S; Lehnert M; Ludwig H
Ther Umsch; 2010 May; 67(5):271-6. PubMed ID: 20509125
[TBL] [Abstract][Full Text] [Related]
2. Erythropoiesis-stimulating protein support and survival.
Crawford J
Oncology (Williston Park); 2006 Jul; 20(8 Suppl 6):39-43. PubMed ID: 16925111
[TBL] [Abstract][Full Text] [Related]
3. [Use of erythropoiesis stimulating agents].
Lapierre A; Souquet PJ
Rev Mal Respir; 2014 Feb; 31(2):162-72. PubMed ID: 24602683
[TBL] [Abstract][Full Text] [Related]
4. Erythropoiesis-stimulating agents (ESAs): do they still have a role in chemotherapy-induced anemia (CIA)?
Bormanis J; Quirt I; Chang J; Kouroukis CT; MacDonald D; Melosky B; Verma S; Couture F
Crit Rev Oncol Hematol; 2013 Aug; 87(2):132-9. PubMed ID: 23357249
[TBL] [Abstract][Full Text] [Related]
5. New ASH/ASCO guidelines on the use of erythropoiesis-stimulating agents: a chorale amid cacophony.
Steensma DP
J Support Oncol; 2007; 5(10):471-3. PubMed ID: 18240668
[No Abstract] [Full Text] [Related]
6. Use of biosimilar epoetin to increase hemoglobin levels in patients with chemotherapy-induced anemia: real-life clinical experience.
Kerkhofs L; Boschetti G; Lugini A; Stanculeanu DL; Palomo AG
Future Oncol; 2012 Jun; 8(6):751-6. PubMed ID: 22443466
[TBL] [Abstract][Full Text] [Related]
7. Management of anemia in cancer patients.
Calabrich A; Katz A
Future Oncol; 2011 Apr; 7(4):507-17. PubMed ID: 21463140
[TBL] [Abstract][Full Text] [Related]
8. Erythropoiesis-stimulating agents: favorable safety profile when used as indicated.
Nowrousian MR; Dunst J; Vaupel P
Strahlenther Onkol; 2008 Mar; 184(3):121-36. PubMed ID: 18330508
[TBL] [Abstract][Full Text] [Related]
9. Treatment options for anemia, taking risks into consideration: erythropoiesis-stimulating agents versus transfusions.
Spano JP; Khayat D
Oncologist; 2008; 13 Suppl 3():27-32. PubMed ID: 18458122
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolic events and erythropoiesis-stimulating agents: an update.
Dicato M
Oncologist; 2008; 13 Suppl 3():11-5. PubMed ID: 18458119
[TBL] [Abstract][Full Text] [Related]
11. Anemia in cancer patients: significance, epidemiology, and current therapy.
Tchekmedyian NS
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):17-24. PubMed ID: 12380951
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.
Crawford J
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):41-53. PubMed ID: 12380954
[TBL] [Abstract][Full Text] [Related]
13. Cancer-related anaemia management in the 21st century.
Pronzato P
Cancer Treat Rev; 2006; 32 Suppl 2():S1-3. PubMed ID: 16725269
[TBL] [Abstract][Full Text] [Related]
14. Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer.
Hershman DL; Buono DL; Malin J; McBride R; Tsai WY; Neugut AI
J Natl Cancer Inst; 2009 Dec; 101(23):1633-41. PubMed ID: 19903808
[TBL] [Abstract][Full Text] [Related]
15. Management of chemotherapy-induced anemia.
Eguchi K
Curr Opin Oncol; 1995 Jul; 7(4):316-9. PubMed ID: 7578378
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial.
; Glaspy J; Vadhan-Raj S; Patel R; Bosserman L; Hu E; Lloyd RE; Boccia RV; Tomita D; Rossi G
J Clin Oncol; 2006 May; 24(15):2290-7. PubMed ID: 16710026
[TBL] [Abstract][Full Text] [Related]
17. Continued challenges with the use of erythropoiesis-stimulating agents in patients with cancer: perspectives and issues on policy-guided health care.
Arbuckle RB; Griffith NL; Iacovelli LM; Johnson PE; Jorgenson JA; Kloth DD; Lucarelli CD; Muller RJ
Pharmacotherapy; 2008 May; 28(5 Pt 2):1S-15S. PubMed ID: 18447704
[TBL] [Abstract][Full Text] [Related]
18. [Treatment with beta-erythropoietin in lung cancer--effectiveness and quality of life improvement in clinical practice].
Tamási L; Gálffy G
Orv Hetil; 2010 Oct; 151(41):1684-8. PubMed ID: 20880802
[TBL] [Abstract][Full Text] [Related]
19. Benefits of early intervention with erythropoiesis- stimulating proteins in chemotherapy-induced anemia.
Lyman GH
Oncology (Williston Park); 2006 Jul; 20(8 Suppl 6):16-20. PubMed ID: 16925106
[TBL] [Abstract][Full Text] [Related]
20. ESAs further restricted, but debate continues.
Brower V
J Natl Cancer Inst; 2008 Oct; 100(19):1344-51. PubMed ID: 18812542
[No Abstract] [Full Text] [Related]
[Next] [New Search]